21 CFR Part 11 Subpart C-Electronic Signatures

Поделиться
HTML-код
  • Опубликовано: 9 ноя 2024

Комментарии • 2

  • @repallemuralidhar
    @repallemuralidhar 9 месяцев назад

    Nowadays this topic is very useful in pharmaceutical industry to maintain and secure the data as per the current guidelines formulated by regulatory bodies.

    • @pharmaworldk1473
      @pharmaworldk1473  9 месяцев назад

      Yes. There should be a detailed policy or SOP in the organization to capture all these requirements to handle electronic data recording through electronic signatures.